Aarti Drugs Limited has announced the opening of a special window for re-lodgement of transfer requests of physical shares, providing an opportunity for eligible investors to complete pending share transfers. The company published newspaper advertisements on April 8, 2026, in Financial Express (English) and Pratabhkal (Marathi) to inform shareholders about this facility.

Special Window Details

The special window for transfer and dematerialisation of physical shares will remain open until February 4, 2027, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. This facility specifically targets investors who purchased physical shares of Aarti Drugs Limited prior to April 1, 2019.

Eligibility Criteria

The facility is available for investors who fall into two specific categories:

• Investors who had not lodged their shares for transfer
• Investors who had lodged shares for transfer but the requests were rejected, returned, or not attended due to deficiencies in documentation

Applicability Matrix

The company has provided a detailed matrix to clarify eligibility for the special window:

Documentation Requirements

Only requests accompanied by original share certificates along with transfer deeds and other supporting documents will be considered under the special window. Investors must ensure they have all required original documentation before approaching the registrar.

Contact Information

Investors wishing to avail this facility should contact the company's Registrar and Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), located at C-101, 247 Park, LBS Marg, Vikhroli (West), Mumbai - 400083. Queries can be addressed to mt.helpdesk@in.mpms.mufg.com , and additional details are available in the SEBI Circular at www.sebi.gov.in .

Aarti Drugs Limited has announced the launch of the Second 100 Days Campaign – "Saksham Niveshak" following a directive from the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs (MCA). The campaign, running from April 1, 2026 to July 9, 2026, aims to help shareholders claim unpaid or unclaimed dividends and update their KYC details. The company has now published newspaper advertisements and notified stock exchanges under regulatory compliance requirements.

Regulatory Compliance and Publication Details

Aarti Drugs Limited has fulfilled its regulatory obligations by notifying both BSE Limited and National Stock Exchange of India Limited about the newspaper publication of the campaign notice. The company submitted its compliance letter dated April 7, 2026, under reference ADL/SE/2026-27/03, in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Campaign Overview and Purpose

The IEPFA, through its communication dated March 27, 2026, has requested companies to relaunch this initiative to reach out to shareholders whose dividends remain unpaid or unclaimed. The primary objective is to create awareness among shareholders to update their KYC-related details and claim any outstanding dividends before they get transferred to the Investor Education and Protection Fund (IEPF).

Required Documentation and Submission Process

Shareholders need to submit specific forms and documents to claim their unpaid dividends and update their information:

Submission Channels and Contact Information

Shareholders can submit their documents through multiple channels to MUFG Intime India Private Limited, the company's Registrar & Share Transfer Agent:

Important Guidelines and IEPF Transfer

Shareholders must update essential information including PAN details, nomination details, contact information, bank account details, and specimen signatures. Since dividends are payable only through electronic mode, amounts will be credited to shareholders' bank accounts only after required information is updated. The company emphasizes that dividend amounts not claimed for seven consecutive years will result in transfer of corresponding equity shares to the IEPF Authority.

The campaign notice is available on the company's website and stock exchange websites. Shareholders are encouraged to submit their documents by July 9, 2026 to ensure successful claim of unpaid dividends and prevent share transfer to IEPFA.